
News|Articles|November 15, 2016
- Pharmaceutical Technology-11-15-2016
- Volume 2016 eBook
- Issue 3
Is Global Regulatory Gridlock Slowing Modernization?
Author(s)Agnes Shanley
PDA’s first aging facilities survey suggests that post-approval changes play a major part in slowing pharmaceutical industry investment in new technology.
Advertisement
Maik Jornitz, who chaired the aging facilities taskforce during its first year, discusses challenges and what is required for change.
Download Pharmaceutical Technology’s
.
Articles in this issue
about 10 years ago
Extending QMS to Contract Partnersabout 10 years ago
Investigation Effectiveness Drives Human Performance Excellenceabout 10 years ago
Paperless Batch Records for the Massesabout 10 years ago
Ensuring Quality in Pharmaceutical Raw Materialsabout 10 years ago
Microbiological Testing: Time is of the EssenceAdvertisement
Related to this article

How confident is the bio/pharma workforce heading into 2027? PharmTech wants to find out, and we need your input.

Cole and Jaenisch explain where pharma should keep manual checks, how to vet AI skills in hires, and why self-taught AI risks GMP.

Cole and Jaenisch explain why defending against AI poisoning in pharma manufacturing calls for a data steward role, immutable instruction ledgers, and automation.

Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how the company’s product is worth the investment by protecting products and patients.

Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.

Terry Katz, CEO and cofounder of ForgeStop Technology Corporation, explains the company’s CPHI Award-winning connected product technology and how it helps to combat drug counterfeiting.

Coverage from AAPS PharmSci 360 and CPHI Milan featured discussion about impurities, devices, and supply resilience. This week also included topics such as AI accountability, oral peptides, and new licensing deals.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Challenges in Oral Delivery of Peptides: Bioavailability
2
What Venglustat’s Approval Means for Rare Disease Developers
3
Manufacturing Intelligence: Where Pharma Should Slow AI
4
New Proposals and Legislation Strengthen Europe’s Position in the Pharmaceutical Arena
5


